May 28, 2020

May 27, 2020

Subscribe to Latest Legal News and Analysis

May 26, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
12
Aug
Sham Hatch-Waxman Infringement Suits And FDA Citizen Petitions; A Potential For New Liability For Innovators? Sheppard, Mullin, Richter & Hampton LLP
11
Aug
FDA Notifies Congress that It Intends to Regulate Laboratory Developed Tests Barnes & Thornburg LLP
11
Aug
MHRA creates new expert advisory group on medical devices Covington & Burling LLP
8
Aug
FDA Announces Intent to Issue Draft Guidance Documents Describing Regulatory Framework for Laboratory Developed Tests Covington & Burling LLP
8
Aug
Medical Devices: Parallel Claims Against Device Manufacturers post-Riegel? Sills Cummis & Gross P.C.
8
Aug
NLRB’s Sobering Decision Permits Union Representation Before Employee Drug Test Jackson Lewis P.C.
7
Aug
FDA Releases Final Guidance on Expedited Center for Devices and Radiological Health (CDRH) Appeals Barnes & Thornburg LLP
7
Aug
3D-Matrix, Ltd. v. Menicon Co., Ltd., Denying Institution of Inter Partes Review IPR2014-00398 Faegre Drinker
7
Aug
Fed. Cir.: Antitrust Issues Can Arise From Hatch-Waxman Litigation Schwegman, Lundberg & Woessner, P.A.
6
Aug
Anticipated Framework for Regulatory Oversight of Laboratory Developed Tests McDermott Will & Emery
6
Aug
Medical Device Update: FDA Issues Final Guidance on 510(k) Determinations, Use of “Split” Predicates Strongly Discouraged Morgan, Lewis & Bockius LLP
6
Aug
D.C. Circuit Rejects Toxic Tort Claims Based on Aerial Spraying of Herbicide Beveridge & Diamond PC
5
Aug
Summary Of FDA Advertising and Promotion Enforcement Activities Covington & Burling LLP
5
Aug
The Electronic Wallet System: How Nigeria Is Dialing Into Its Agricultural Sector Covington & Burling LLP
4
Aug
Ignorance is Bliss – for Teva re: Structural Obviousness in Patent Cases Schwegman, Lundberg & Woessner, P.A.
4
Aug
Commission Updates EU Medical Devices Borderline Manual Covington & Burling LLP
4
Aug
FDA Issues Updated Draft Guidance on Reporting Drug Samples Morgan, Lewis & Bockius LLP
3
Aug
EcoWater Systems LLC v. Culligan International Co., Inter Partes Review Still Difficult for Patent Owners McDermott Will & Emery
3
Aug
Dissent at the Patent Trial and Appeal Board (PTAB) Leads to … Unpatentability McDermott Will & Emery
2
Aug
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc., Denying Institution IPR2014-00361 Faegre Drinker

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS